Alembic Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 2010.
2010 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited, a active public limited company, was established on 16 June 2010 in Vadodara, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24230GJ2010PLC061123. Registered under ROC Roc Ahmedabad. it is listed on BSE: 533573 and NSE: APLLTD. It has an authorized capital of ₹40.50 Cr and a paid-up capital of ₹39.31 Cr.

Formerly known as Alembic Pharma Limited. It upholds a compliant status. In 2023, it reported revenue of ₹5,152.55 Cr and a net worth of ₹4,414.29 Cr. Employing 15,822 professional, Its leadership includes Ashok Kumar Barat (Director), Geeta Amit Goradia (Director), Shaunak Chirayu Amin (Managing Director). Past directors included Pranav Natverlal Parikh, Ashok Kumar Barat, Archana Niranjan Hingorani. It holds ₹600.00 Cr open charges and ₹219.36 Cr settled loans. Its latest AGM occurred on 05 August 2025, with the balance sheet filed on 31 March 2025. It is based at Alembic Road,, Vadodara, Gujarat, 390003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24230GJ2010PLC061123

  • Registration Number

    061123

  • Incorporation Date

    16 June 2010

  • Authorized Capital

    ₹40.50 Cr

  • Paid-Up Capital

    ₹39.31 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 533573, NSE: APLLTD)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 40.50 Cr
  • Paid Up Capital ₹ 39.31 Cr
  • Company Age 15 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 600.00 Cr
  • Satisfied Charges ₹ 219.36 Cr
  • Revenue Growth **** 1.30%
  • Profit Growth **** -36.21%
  • Ebitda **** -26.90%
  • Net Worth -16.56%
  • Total Assets -13.34%
Company report

Alembic Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Alembic Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Alembic Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Ashok Kumar Barat Director 10 Feb 2022 Current
Geeta Amit Goradia Director 03 Feb 2025 Current
Shaunak Chirayu Amin Managing Director 02 May 2013 Current
Rajkumar Shreeram Baheti Whole-Time Director 16 Jun 2010 Current
Manisha Saraf Nodal Officer 08 Apr 2023 Current
Manish Santoshkumar Kejriwal Director 31 Mar 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Aug 2011 Past
Pramod Abcsdd Additional Director 17 Mar 2022 Past
Pramod Abcsdd Additional Director 31 Jul 2015 Past
Pramod Abcsdd Additional Director 15 Mar 2025 Past
Pramod Abcsdd Director 31 Mar 2011 Past
Pramod Abcsdd Whole-Time Director 06 Aug 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Alembic Pharmaceuticals.

Alembic Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.3% increase. The company also saw a substantial fall in profitability, with a 36.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.56%.

Alembic Pharmaceuticals revenue growth over time
Alembic Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 1.30%
*******
*******
*******
*******
Revenue from Operations
*******
 2.26%
*******
*******
*******
*******
Total Assets
*******
 -13.34%
*******
*******
*******
*******
Profit or Loss
*******
 -36.21%
*******
*******
*******
*******
Net Worth
*******
 -16.56%
*******
*******
*******
*******
EBITDA
*******
 -26.90%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Alembic Pharmaceuticals?

In 2023, Alembic Pharmaceuticals had a promoter holding of 69.61% and a public holding of 30.40%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,000,000,000.00

Satisfied Charges

₹2,193,630,734.00

Charges Breakdown by Lending Institutions
  • Others : 600.00 Cr
Latest Charge Details
Date Lender Amount Status
30 Jun 2011 Others ₹600.00 Cr Open
19 Nov 2021 Hdfc Bank Limited ₹5.00 Cr Satisfied
26 Jul 2021 Yes Bank Limited ₹10.00 Cr Satisfied
08 May 2014 Bank Of Baroda ₹1.36 Cr Satisfied
02 Dec 2011 Dbs Bank Limited ₹78.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Alembic Pharmaceuticals?

Alembic Pharmaceuticals has a workforce of 15822 employees as of Feb 11, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Alembic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alembic Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Alembic Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Alembic Pharmaceuticals Limited last Annual general meeting of members was held on 05 Aug 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Alembic Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    Progress on Geeta Amit Goradia was appointed as a Director was appointed as a Director on 03 Feb 2025 & has been associated with this company since 1 year 8 days . was documented.

  • Director Appointment

    The activity Manish Santoshkumar Kejriwal was appointed as a Director was appointed as a Director on 31 Mar 2024 & has been associated with this company since 1 year 10 months . was completed.

  • Charges

    The activity A charge registered on 26 Jul 2021 via Charge ID 100469987 with Yes Bank Limited was fully satisfied on 13 Jun 2023. was completed.

  • Director Appointment

    Jai Shishir Diwanji was appointed as a Director was appointed as a Director on 05 May 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Alembic Pharmaceuticals Limited?

The CIN of Alembic Pharmaceuticals Limited is L24230GJ2010PLC061123.

Where is Alembic Pharmaceuticals Limited headquartered?

Alembic Pharmaceuticals Limited is headquartered at Alembic Road,, Vadodara, Gujarat, 390003.

When was Alembic Pharmaceuticals Limited incorporated?

Alembic Pharmaceuticals Limited was incorporated on 16 June 2010.

Who are the current directors of Alembic Pharmaceuticals Limited?

The current directors of Alembic Pharmaceuticals Limited are

What is the primary industry of Alembic Pharmaceuticals Limited?

The primary industry of Alembic Pharmaceuticals Limited is Manufacturing.

Is Alembic Pharmaceuticals Limited a listed company?

Alembic Pharmaceuticals Limited is listed. It is listed on BSE: 533573 and NSE: APLLTD.

What is the capital structure of Alembic Pharmaceuticals Limited?

The authorized capital of Alembic Pharmaceuticals Limited is ₹40.50 Cr, and the paid-up capital is ₹39.31 Cr.

What is the compliance status of Alembic Pharmaceuticals Limited?

The compliance status of Alembic Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available